Moreover, existing study reveals that sesamin could promote osteogenesis by upregulating the Wnt/β-catenin pathway and inhibit osteoclastogenesis by downregulating the NF-κB pathway, suggesting that it could be a therapeutic medication for osteoporosis treatment [37]. The gene discussed is NFKB1; the disease is osteoporosis.